Pharmaceuticals
Company Overview of Altor BioScience Corporation
Executive Profile
Jedd D. Wolchok M.D., Ph.D.Member of Scientific Advisory Board - Melanoma, Altor BioScience Corporation |
| Age | Total Calculated Compensation | This person is connected to 2 Board Members in 2 different organizations across 2 different industries. See Board Relationships |
| -- | -- |
Background
Dr. Jedd Wolchok, M.D. Ph.D. serves as a Co-Editor at Cytokines, Cellular and Molecular Therapy. Dr. Wolchok is an Associate Professor of Memorial Sloan-Kettering Cancer Center, New York. He serves as Member of Clinical Advisory Board of Altor BioScience Corporation. He serves as Associate Director of the Scientific Advisory Council at Cancer Research Institute, Inc. He served as Director of the Cancer Vaccine Collaborative at Cancer Research Institute, Inc. Dr. Wolchok ...
Corporate Headquarters2810 North Commerce ParkwayMiramar, Florida 33025-3958 United States Phone: 954-443-8600 Fax: 954-443-8610 Board Members MembershipsThere is no Board Members Memberships data available.EducationMD NYU Elaine A. and Kenneth G. Langone Medical Center
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Riverside, CA | AbbviePosted: May 20
- New York, NY | Healthcare SpecialistsPosted: May 20
Sponsored Financial Commentaries
Sponsored Links
To contact Altor BioScience Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








